 Fremont, CA, March 23, 2022 GLOBE NEWSWIRE -- via NewMediaWire -- ABVC Biopharma, Inc. NASDAQ: ABVC, a clinical stage biopharmaceutical company developing therapeutic solutions in oncologyhematology, CNS, and ophthalmology, today announced that the company will be participating at the Maxim Group 2022 Virtual Growth Conference, taking place March 28-30, 2022. 